Mitochondrial Disease
Resources
Get Involved
Research
About Us
Donate
Donate Now
Energy for Life
Family Impact Fund
Match Your Gift
Get Support
UMDF Cosigns Letter to New Administration Outlining Rare Disease Priorities
Mito Advocacy
,
Press Room
Last Updated:
Jan 27, 2025 @ 11:04 am
Search for:
Categories
About Mito
Adult Resources
Coronavirus
Corporate Partner
Donor Spotlight
Fundraising
Mito Champion Spotlight
Position Statements
Research News
Conference
Recent Posts
Ask Congress to review the FDA’s decision not to approve elamipretide for Barth Syndrome and encourage thorough review and reform of the FDA’s rare disease therapy evaluation process
June Newsletter: FDA News, accelerators Finalists, Mito Med 2025, and More
Learn More about PRMRP Mito Research Opportunities for FY25; Pre-applications Due June 9
UMDF Statement on the FDA’s Elamipretide Decision
A Special Message from New UMDF President & CEO Kristen Clifford
UMDF and The Mito Foundation Announce Research Grant Partnership
Related Posts
Ask Congress to review the FDA’s decision not to app...
Read more
June Newsletter: FDA News, accelerators Finalists, Mit...
Read more
Learn More about PRMRP Mito Research Opportunities for...
Read more
